Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

shutterstock_274590824

Biogen stock surges following patent victory over Mylan for Tecfidera

February 6, 2020
Sales and Marketing Biogen, Mylan, multiple sclerosis, pharma, tecfidera

Biogen has emerged victorious in a patent dispute with Mylan relating to the latter’s multiple sclerosis therapy Tecfidera – a …

News

Bayer’s Eylea shows strong vision benefits across two regimens in post-marketing study

February 5, 2020
Research and Development Bayer, Eylea, pharma

Bayer has pulled back the curtain on new Phase 4 data for Eylea (aflibercept), revealing strong findings in the treatment …

News
holly_springs_9frontflags

Seqirus’ Audenz becomes first FDA-approved cell-based adjuvant influenza A vaccine

February 5, 2020
Research and Development, Sales and Marketing FDA, influenza, pharma, seqirus

The FDA has just approved the first adjuvanted, cell-based vaccine for the prevention of influenza A (H5N1) in the US, …

News

Europe’s CHMP recommends Pfizer’s biosimilar of Roche’s MabThera

February 4, 2020
Manufacturing and Production, Sales and Marketing MabThera, Pfizer, Ruxience, biosimilar, pharma

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has revealed that it has awarded a positive opinion for …

News

National Institutes of Health terminates HIV vaccine after it proves ineffective

February 4, 2020
Manufacturing and Production HIV, pharma

A trial investigating the efficacy  of a new HIV vaccine conducted by the National Institute of Allergy and Infectious Diseases …

News

Insider Interview: Reducing the risk of adverse cardiovascular events

February 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Insider Interview, cardiovascular, heart disease, pharma

Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …

Feature
abbvie_0

AbbVie’s Venclyxto pins down CHMP approval for treatment-naive chronic lymphocytic leukaemia

February 3, 2020
Sales and Marketing AbbVie, CHMP, EMA, Venclyxto, pharma

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has awarded recommendation to AbbVie’s Venclyxto (venetoclax), …

News
512px-gwyneth_paltrow_avp_iron_man_3_paris_2

NHS Chief Simon Stevens: Gwyneth Paltrow’s Goop poses “considerable risks to health”

January 31, 2020
Medical Communications Goop, Gwyneth Platrow, NHS, Simon Stevens, pharma

NHS Chief Executive Simon Stevens has gone head-to-head with Hollywood actor and “wellness guru” Gwyneth Paltrow, taking aim at her …

News
shutterstock_159488225

Bayer and Orion’s Nubeqa shows off strong overall survival benefit in castration-resistant prostate cancer

January 31, 2020
Medical Communications, Research and Development Bayer, orion, pharma

Bayer and Finnish pharma firm Orion Corporation have announced positive new Phase 3 data for their jointly developed oral androgen …

News
pharmafocus_janfeb_2020_cover

Read the January/February 2020 edition of Pharmafocus online now!

January 30, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, US, brexit, coronavirus, opioid crisis, pharma

Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …

News
shutterstock_36423250

Spring Bank Pharma shuts down HBV drug development following patient death

January 30, 2020
Research and Development Spring Bank, patient death, pharma

Biopharma firm Spring Bank Pharmaceuticals has revealed it has taken the decision to terminate all further development of inarigivir soproxil …

News
janssen_latest_logo_on_sign_closer

Janssen’s Erleada expanded in Europe to cover metastatic hormone-sensitive prostate cancer

January 29, 2020
Research and Development, Sales and Marketing Erleada, Europe, Janssen, pharma

Janssen’s Erleada (apalutamide) has secured expanded authorisation from the European Commission (EC), approving its label to include the treatment of …

News
teva_copy

FDA approves Teva’s Ajovy autoinjector for treatment of migraine

January 29, 2020
Research and Development, Sales and Marketing FDA, Teva, ajovy, migraine, pharma

Israeli pharma firm Teva has revealed that the FDA has chosen to award approval to its autoinjector device for the …

News
shutterstock_243110086

Lilly & Incyte’s Olumiant hits main goal in atopic dermatitis

January 28, 2020
Manufacturing and Production, Research and Development Eli Lilly, Olumiant, pharma

Eli Lilly and Incyte have lifted the curtain on new Phase 3 data showing that their oral JAK inhibitor, showing …

News
lynn_taylor_updated_headshot_web

Realising the potential of greater collaboration for women living with cancer

January 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Merck KGaA, feature, pharma, women

Following the launch of a new global report, ‘Supporting women with cancer’, Lynn Talyroe, Senior Vice President, Head of Healthcare …

Feature
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026